Form D · Biotechnology

Vestagen Protective Technologies, Inc.

Orlando, FL · CIK 0001584606

Offering snapshot reported Apr 12, 2017 · SEC filing

Reported sold
$16M
Offering amount: $21M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 31, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 12, 2017Initial$15,989,010No comparison8SEC filing
Feb 1, 2017Initial$500,000No comparison4SEC filing
Sep 15, 2015Initial$3,300,000No comparison7SEC filing
Aug 16, 2013Initial$5,751,781No comparison6SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-284612

Source: Form D, filed Apr 12, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
William M. Bold Director, Executive
Uncas Benjamin Favret, Iii Director, Executive
Rick Ferreira Director
James Karides Director
Joe Meyernik Director
David Nash Director
Dale Pfost Director
Randy Scott Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1301 W. Colonial Road
Orlando, FL, 32804